Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Clinical development of C-peptide for prevention and treatment of diabetes complications

Reference number
Coordinator Cebix AB
Funding from Vinnova SEK 75 000
Project duration August 2010 - October 2010
Status Completed

Last updated 25 November 2019

Reference number 2010-01729

Page statistics